Active Biotech AB (STU:BTP) ROE % Adjusted to Book Value: -23.23% (As of Mar. 2026)


STU:BTP Active Biotech AB STU:BTP
28 GF Score
Price €0.50
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB ROE % Adjusted to Book Value?

Active Biotech AB STU:BTP 28 ROE % Adjusted to Book Value is -23.23% as of Mar. 2026. GuruFocus rates STU:BTP with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Active Biotech AB's ROE % for the quarter that ended in Mar. 2026 was -65.74%. Active Biotech AB's PB Ratio for the quarter that ended in Mar. 2026 was 2.83. Active Biotech AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -23.23%.

Active Biotech AB ROE % Adjusted to Book Value Related Terms

Active Biotech AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB ROE % Adjusted to Book Value Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.70 -13.71 -23.60 -13.25 -83.70

Active Biotech AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.47 -13.11 -5.55 -117.65 -23.23

STU:BTP vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Active Biotech AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Active Biotech AB ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's ROE % Adjusted to Book Value falls into.


STU:BTP
28GF Score
Active Biotech AB STU:BTP
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB ROE % Adjusted to Book Value Calculation

Active Biotech AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-86.21% / 1.03
=-83.70%

Active Biotech AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-65.74% / 2.83
=-23.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -23.23% mean?
Active Biotech AB (STU:BTP) has a ROE % Adjusted to Book Value of -23.23% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Active Biotech AB and its competitors.
Is Active Biotech AB's ROE % Adjusted to Book Value too high?
Active Biotech AB's current ROE % Adjusted to Book Value is -23.23%. Overall, Active Biotech AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's ROE % Adjusted to Book Value compare to VRTX and REGN?
Active Biotech AB's ROE % Adjusted to Book Value of -23.23% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Active Biotech AB and its competitors. Active Biotech AB's current ROE % Adjusted to Book Value is -23.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (STU:BTP) has a current ROE % Adjusted to Book Value of -23.23%. The current ROE % Adjusted to Book Value is -23.23%. Active Biotech AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Active Biotech AB (STU:BTP), the current ROE % Adjusted to Book Value is -23.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Active Biotech AB Business Description

Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
28GF Score

Get the complete analysis for STU:BTP

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price